Megan Knight
Investor Relations Contact chez ARENA PHARMACEUTICALS
Profil
Megan E.
Knight is currently the Director-Investor Relations at Arena Pharmaceuticals, Inc. and the Vice President & Head-Investor Relations at Longboard Pharmaceuticals, Inc. She previously worked as the Head-Investor Relations & Corporate Communications at Senomyx, Inc.
Postes actifs de Megan Knight
| Sociétés | Poste | Début |
|---|---|---|
| ARENA PHARMACEUTICALS | Investor Relations Contact | - |
| LONGBOARD PHARMACEUTICALS, INC. | Investor Relations Contact | 01/01/2021 |
Anciens postes connus de Megan Knight
| Sociétés | Poste | Fin |
|---|---|---|
| SENOMYX INC. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LONGBOARD PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA. | Consumer Non-Durables |
